Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Company gets green light for CYT997 trial
May 26th, 2005
Up to 30 patients with advanced incurable solid-tumors are to be involved in clinical trials of a new anticancer drug (CYT997), developed by Australian biotechnology company, Cytopia, Ltd. Cytopia Managing Director Dr. Kevin Healey said the company had obtained the necessary ethics approvals to begin clinical trials at the Royal Brisbane and Women's Hospital in association with the Queensland Institute of Medical Research and Q-Pharm Pty, Ltd. The tests will be supervised by leading ovarian oncologist, Dr. Paul Vasey, and medical oncologist, Dr. Jason Lickliter. "In animal studies, CYT997 was highly effective in killing cancer cells including...
Source: Women's Health Weekly (2005-05-26)
|
